CIDRAP newsletters options
In another development, the WHO announced the next phase of a treatment trial, which will test three repurposed drugs across 52 countries.
Inhaled budesonide, a corticosteroid often used for Crohn's disease, was tied to a shorter recovery time in COVID-19 patients who were at a higher risk of severe infection, according to a study published in The Lancet yesterday.
The proportion of multidrug-resistant Escherichia coli and Klebsiella pneumoniae found in Canadian hospital patients increased substantially from 2007 through 2018, according to a surveillance study published today in the Journal of Antimicrobial Chemotherapy.
Researchers continue to say the vaccines' health benefits outweigh any risks.
Some Florida and Texas districts are defying state orders against mask mandates, as more groups mandate vaccination, including the military.
Stubbornly high levels persist in nations including Thailand and Vietnam as Delta variant activity keeps countries on edge, from Australia to China.
Today Morbidity and Mortality Weekly Report (MMWR) published a summary of the findings of the Advisory Committee on Immunization Practices (ACIP) on adverse events related to the three COVID-19 vaccines approved for emergency use in the United States, two-dose mRNA vaccines from Pfizer and Moderna, and a single shot adenovirus vaccine from Johnson & Johnson.
Data suggest that, during the pandemic, at least 20% have had depression or anxiety.
Indonesia's activity picked up on other islands, as more Australian cities in New South Wales state went into lockdown.
Doctors are pushing for authorized vaccinations for children and adolescents ahead of the school year.
Guinea's ministry of health (MOH) has confirmed the country's first Marburg virus case, also marking the first in West Africa, the World Health Organization (WHO) African regional office said today in a statement.
A survey of US caregivers found that more than 1 in 10 either planned or had already administered a nonprescription antibiotic (NPA) to their child, researchers reported last week in the Journal of the Pediatric Infectious Diseases Society.
Secondary attack rates dropped from 31% to 11% if the index patient was vaccinated.
Also, Asian countries continue to grapple with new cases, with Japan reporting another record daily high.
Reducing resistance may require more than cutting antibiotic use alone.
Chinese officials reported two more H5N6 avian influenza infections in patients from two different provinces, raising the country's total this year to 13, the Hong Kong Centre for Health Protection (CHP) said today in a statement.
COVID-19 antibodies remained 7 months' post-infection, with some even increasing in levels, according to a follow-up study of 578 healthcare workers at the Hospital Clínic at Barcelona. The results, which were published today in Nature Communications, also include evidence that exposure to common cold coronaviruses may contribute to some cross protection.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The antibody cocktail reduced the risk of COVID-19 by 66% to 81%.
About 500,000 cases are being added to the global total each day, and the Delta variant is now in 135 countries.
